About AquaBounty
AquaBounty is a company based in Maynard (United States) founded in 1991. AquaBounty has raised $10 million across 9 funding rounds from investors including Precigen, Prince Edward Island and National Science Foundation. The company has 4 employees as of December 31, 2024. AquaBounty operates in a competitive market with competitors including Regional Fish, Benchmark Genetics, Genomar Genetics, Xelect and VeroBlue Farms, among others.
- Headquarter Maynard, United States
- Employees 4 as on 31 Dec, 2024
- Stage Public
-
Sectors
Agriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aquabounty Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$149.19 M (USD)-441.38as on Dec 31, 2024
-
EBITDA
-$8.62 M (USD)25.13as on Dec 31, 2024
-
Total Equity Funding
$10 M (USD)
in 9 rounds
-
Latest Funding Round
Not available
-
Investors
Precigen
& 2 more
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of AquaBounty
AquaBounty is a publicly listed company on the NASDAQ with ticker symbol AQB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of AquaBounty
Unlock access to complete
Funding Insights of AquaBounty
AquaBounty has successfully raised a total of $10M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AquaBounty
AquaBounty has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Precigen, Prince Edward Island and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for AquaBounty
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AquaBounty
Investment portfolio details for AquaBounty
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AquaBounty
Detailed financials for AquaBounty
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aquabounty Comparisons
Peer comparison for AquaBounty
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AquaBounty
AquaBounty operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Regional Fish, Benchmark Genetics, Genomar Genetics, Xelect and VeroBlue Farms, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Tech-based breeding solutions for fishes
|
|
| Locked | Locked | Locked |
Genetic breeding services for aquaculture species are provided.
|
|
| Locked | Locked | Locked |
Provider of breeding technology for tilapia fishes and supply of broodstock & fingerlings
|
|
| Locked | Locked | Locked |
Genetic breeding for seafood products is conducted by Xelect.
|
|
| Locked | Locked | Locked |
Barramundi fish is bred and harvested inland using aquaculture tanks.
|
Detailed competitors of AquaBounty
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aquabounty
Complete news archive for AquaBounty
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AquaBounty
AquaBounty was founded in 1991 and raised its 1st funding round 18 years after it was founded.
AquaBounty is headquartered in Maynard, United States. It is registered at Maynard, Massachusetts, United States.
AquaBounty is a funded company, having raised a total of $10M across 9 funding rounds to date.
As of Dec 31, 2024, the latest employee count at AquaBounty is 4.
Founded in 1991 and based in Maynard, United States, AquaBounty operates in the aquaculture sector. Hybrid salmon, trout, and tilapia are developed and produced, including the patented AquAdvantage Salmon, a sterile Atlantic salmon female that reaches market size in half the time of conventional varieties. Antifreeze proteins are also manufactured, while research and development programs focus on cryopreservatives and antifreeze gene constructs for commercialization.
AquaBounty's top competitors include Benchmark Genetics, Regional Fish and Genomar Genetics.
Yes, AquaBounty is publicly traded on NASDAQ under the ticker symbol AQB.
AquaBounty has 3 investors. Key investors include Precigen, Prince Edward Island, and National Science Foundation.
The ticker symbol of AquaBounty is AQB on NASDAQ.